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Background: Despite the major public health impact of diabetes, recent population-based data regarding its
prevalence and comorbidity are sparse.
Methods: The prevalence and comorbidity of diabetes mellitus were analyzed in a nationally representative sample
(N = 9133) of the non-institutionalized German adult population aged 50 years and older. Information on physician-
diagnosed diabetes and 20 other chronic health conditions was collected as part of the national telephone health
interview survey ‘German Health Update (GEDA)’ 2009. Overall, 51.2% of contacted persons participated. Among
persons with diabetes, diabetes severity was defined according to the type and number of diabetes-concordant
conditions: no diabetes-concordant condition (grade 1); hypertension and/or hyperlipidemia only (grade 2); one
comorbidity likely to represent diabetes-related micro- or macrovascular end-organ damage (grade 3); several such
comorbidities (grade 4). Determinants of diabetes severity were analyzed by multivariable ordinal regression.
Results: The 12-month prevalence of diabetes was 13.6% with no significant difference between men and women.
Persons with diabetes had a significantly higher prevalence and average number of diabetes-concordant as well as
diabetes-discordant comorbidities than persons without diabetes. Among persons with diabetes, 10.2%, 46.8%,
35.6% and 7.4% were classified as having severity grade 1–4, respectively. Determinants of diabetes severity
included age (cumulative odds ratio 1.05, 95% confidence interval 1.03-1.07, per year) and number of discordant
comorbidities (1.40, 1.25-1.55). With respect to specific discordant comorbidities, diabetes severity was correlated to
depression (2.15, 1.29-3.56), respiratory disease (2.75, 1.72-4.41), musculoskeletal disease (1.53, 1.06-2.21), and severe
hearing impairment (3.00, 1.21-7.41).
Conclusions: Diabetes is highly prevalent in the non-institutionalized German adult population 50 years and older.
Diabetes comorbidities including diabetes-concordant and diabetes-discordant conditions need to be considered in
epidemiological studies, in order to monitor disease burden and quality of diabetes care. Definitional standards of
diabetes severity need to be refined and consented.
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Diabetes mellitus is a highly common metabolic dis-
order with major public health impact due to its detri-
mental consequences causing severe end-organ damage,
including cardiovascular and neurological complications,
diabetic retinopathy, and diabetic nephropathy [1-3].
Diabetes prevalence has dramatically increased in many
countries over the past decades [4,5]. However, many
countries lack epidemiological studies that permit
surveillance of diabetes prevalence at the national
level. Beyond that, population-based data on diabetes
comorbidity are needed to provide insight into the
burden of disease, to define subgroups with specific
health care needs, and to monitor quality of diabetes
care [2,3,6]. Concomitant health conditions are known to
affect both the course and outcome of the disease treat-
ment [2,3,7-9]. Thus, guidelines for diabetes mellitus may
need specific adjustments given an increasing number of
older diabetics with multiple health conditions [10].
The prevalence of diabetes among adults in Germany
was estimated in several previous national health surveys
[11] as well as in 5 regional population-based studies
[12] conducted between 1990 and 2005. At the national
level, the prevalence of diabetes among adults 25–65
years ranged between 4.6-5.2% in the earliest and 5.3%
in the latest survey and no significant increase over time
was observed [11]. Diabetes prevalence was found to
vary considerably between regions, with the highest
prevalence estimates found in Northeastern Germany
and the lowest estimates in the South [12]. In addition,
diabetes prevalence among adults in Germany has
been estimated based on statutory health insurance
claim data [13-16] or data collected in the general
practice setting [17,18]. These studies consistently show
higher prevalence estimates compared to results from
population-based studies. A statistically significant in-
crease in prevalence over time was evident from period-
ically repeated analyses of data from a large sickness
fund in the federal state of Hesse [13-15]. No study in
Germany has systematically analyzed diabetes comorbidity
so far. The prevalence and patterns of morbidity and
multimorbidity among older adults in Germany were
analyzed in previous studies based on data from the
2009 national health telephone survey [19] or insurance
claims [20] or general practices [21]. Detailed informa-
tion on diabetes comorbidity was collected in general
practice studies, but only the proportions of patients
with diabetes-specific complications were reported.
Very consistently, nearly half of adults with diabetes
already had either macro- or microvascular complications
[17,18]. Against this background, we used data of the
national health interview survey ‘German Health Up-
date (GEDA)’ 2009 to determine the prevalence of
known diabetes and to analyze patterns of diabetescomorbidity including diabetes-related as well as other
comorbidities in the non-institutionalized population
50 years and older.
Methods
Study design and study population
The national telephone health interview survey Gesund-
heit in Deutschland Aktuell 2009 (German Health Update,
GEDA 2009) was conducted by the Robert Koch Institute
between July 2008 and June 2009 [22]. In GEDA 2009, a
two-stage sampling procedure was applied. First, a pool of
about 223,000 telephone numbers from complete listings
of landline telephone extensions was randomly generated,
applying the Gabler-Häder method [23]. This method
assures that non-private household phone numbers such
as those for public service use, fax numbers as well as
multiple numbers within household are excluded, while
households with unregistered telephone extensions are
included in the ‘target sample’. Secondly, random sam-
pling at the individual level was achieved by the ‘last-
birthday-method’, i.e. the adult household member whose
birthday most closely preceded the date of first contact
to the respective household was included in the target
sample of contact persons [23]. Altogether, 21,262 per-
sons (9,148 men and 12,114 women) of contacted per-
sons 18 years of age and older completed the survey.
This corresponds to a cooperation rate at the individual
level of 51.2%, which represents the cooperation rate
at the respondent level. (Respondent-level cooperation
rates are calculated using contacts with and refusals
from known respondents) [24]. Telephone interviews
were conducted between 10 a.m. and 8.30 p.m., six
days a week. Interviews took an average of 30 minutes.
The study was approved by The Federal Commissioner
for Data Protection and Freedom of Information. Ver-
bal informed consent was provided by all participants
prior to the interview.
The present study was confined to 9,155 adults aged
50 years and older. Among these, 22 persons did not
answer the question concerning a medical history of
diabetes and were hence excluded. Thus, the final study
population consisted of 9,133 adults (3,855 men and
5,278 women).
Data collection and definition of study variables
Using a standardized computer-assisted interview (CATI)
technique, GEDA 2009 collected information regarding
socio-demographic characteristics, health-related behavior
and medical history of diabetes and 20 other chronic
health conditions. Participants were considered to suffer
from diabetes if they answered ‘yes’ to the following
sequence of questions: ‘Has a doctor ever told you that
you have diabetes?’ and ‘Have you been suffering from
diabetes during the past 12 months?’. Information
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medication was not collected. The same criteria as for
diabetes were applied to the definition of any other of
the following health conditions: hyperlipidemia, hyper-
tension, chronic heart failure, asthma, chronic bron-
chitis, chronic renal disease, chronic liver disease,
gastritis or duodenitis, gastric or duodenal ulcer, osteo-
arthritis, rheumatoid arthritis, osteoporosis, depression
and chronic back pain lasting for at least three months.
For the definition of hypertension and hyperlipidemia,
information on current blood pressure or lipid-lowering
medication was available and considered. A history of
cancer, stroke, myocardial infarction (MI) or other cor-
onary heart disease (CHD) such as angina pectoris
(AP) was defined if participants reported a lifetime
medical history, e. g. that these conditions had ever
been diagnosed by a doctor. Assessment of visual or
hearing impairment was based on the European Health
Status Module questions [25]. Participants were asked
if they had any difficulties either in reading printed
newspaper or in identifying the face of a person 4
meters away, using glasses or any other reading aid as
necessary. Hearing impairment was measured by asking
participants if they had any difficulties to follow a con-
versation with several people, using a hearing aid as
necessary. Possible answer choices for the questions
were: (1) can read/hear clearly without difficulty, (2)
can read/hear with some difficulty, (3) can read/hear
with great difficulty and (4) unable to read/hear at
all. Participants in categories ‘3’ or ‘4’ were defined as
experiencing ‘severe visual/hearing impairment’.
Comorbidities were differentiated as diabetes-concordant
or diabetes-discordant based on current evidence in
support of a pathophysiological link to diabetes [26].
Concordant comorbidities included metabolic risk factors
(hypertension and hyperlipidemia) known to be components
of the metabolic syndrome as well as conditions likely
to represent major complications of diabetes, such as
cardiovascular end-organ disease (CVD), chronic renal
disease, and severe visual impairment. Chronic health
conditions other than these were considered as dis-
cordant comorbidities. Individual conditions, whenever
possible, were further grouped according to organ
systems (e. g. heart, cardiovascular, respiratory, digest-
ive musculoskeletal).
Among persons with known diabetes, disease severity
was graded according to the type and number of
diabetes-concordant comorbidities along a four-point
scale: no diabetes-concordant comorbidity (grade 1);
hypertension and/or hyperlipidemia only (grade 2);
one comorbidity likely to represent diabetes-related
complications (grade 3), and several such comorbidities
(grade 4). Grade 3 and 4 diabetes severity levels were
assigned irrespective of cardiometabolic conditions.Body mass index (BMI) was computed from self-
reported measures of body weight and height and
categorized as ‘normal’, ‘overweight’ and ‘obese’ according
to WHO criteria [27]. Smoking status was defined based
on answers to the question ‚Do you smoke – even
occasionally?’ Study participants who answered ‘yes,
daily’ or ‘yes, occasionally’ were defined as current
smokers, while those who answered ‘no, I quit smoking’
or ‘no, I never smoked’ were categorized as ‘ex-smokers’
or ‘non-smokers’, respectively. Sports activity was defined
by the question ’Did you engage in any sports activities
in the past three months?’ Response choices were ‘no’,
‘yes, less than 2 hours/week’, ‘2-4 hours/week’ and ‘more
than 4 hours/week’. Educational attainment was defined
by internationally used CASMIN (Comparative Analysis
of Social Mobility in Industrial Nations) classification
[28]. Considering geographic differences in diabetes
prevalence in Germany [12], regional area of residence
was defined as follows: northern Germany (federal states:
Bremen, Hamburg, Niedersachsen and Schleswig-Holstein);
central Germany (Hessen, Nordrhein-Westfalen, Rheinland-
Pfalz and Saarland); southern Germany (Baden-
Württemberg and Bayern); eastern Germany (Berlin,
Brandenburg, Mecklenburg-Vorpommern, Sachsen, Sachsen-
Anhalt and Thüringen). All federal states in ‘eastern
Germany’ excluding Berlin represent the former
German Democratic Republic (East Germany), while the
others represent the former Federal Republic of Germany
(West Germany).
Statistical methods
SPSS software (version 18.0.3, SPSS Inc. Chicago, IL)
was used for statistical analyses. Descriptive statistics
were used to assess the 12-month prevalence of known
diabetes according to socio-demographic and behav-
ioral characteristics and to assess the prevalence of
comorbidities among persons with and without dia-
betes. The Mann–Whitney-U test and general linear
model procedures were used to compare the median
and mean number of comorbidities between persons
with and without diabetes. The second-order Rao-Scott
chi-square test provided by the SPSS complex sample
procedure was used to test for group differences in
categorical variables. Odds ratios and 95% confidence
intervals (95% CI) as a measure of association between
diabetes and other chronic health conditions were
obtained from logistic regression models adjusting for age,
sex, region of residence, BMI, smoking status, sports
activities, and educational attainment. In order to iden-
tify determinants of diabetes severity, we fitted ordinal
regression models using the grade of diabetes severity
with four possible response levels (grades 1–4) for the
dependent variable. Two separate models were fitted
including the number (model 1) or the type (model 2)
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Sex-specific analyses were performed. Results were
presented for men and women combined, unless there
was evidence for a sex difference based on formal
testing for interaction with sex. All reported results are
weighted. Weights used in the analysis represent a
combination of design weights (adjusting for sampling
design) and adjustment weights (correcting deviations
between the study population and German population
statistics of December 31, 2007 within strata of age,
sex, educational attainment, and residential region)
[22]. The SPSS complex samples procedure was applied
throughout analyses to keep statistical inferences as
conservative as possible. Statistical significance was set
at Alpha < 0.05 based on two-sided tests.
Results
Prevalence of known diabetes by socio-demographic and
behavioral characteristics
Among 9,133 study participants, a total of 1,035 persons
(488 men, 547 women) 50–93 years of age classified as
having known diabetes. The overall weighted 12-month
prevalence was 13.6% with no significant difference
between men and women (Table 1). The prevalence of
diabetes significantly and positively correlated with age
and BMI, whereas a significant and inverse association
existed with educational attainment and sports activity.
Diabetes prevalence was higher among ex-smokers
and non-smokers compared to current smokers. Re-
gional differences were observed, with significantly
higher prevalence estimates in eastern compared to
northern, central or southern federal states. Except for
smoking status, characteristics shown in Table 1 were
significantly and independently associated with diabetes in
multivariable logistic regression models. Results persisted
in sex- specific analyses (data not shown).
Association between diabetes and other chronic health
conditions
Table 2 compares the prevalence of comorbidities be-
tween persons with and without diabetes according to
individual conditions as well as disease categories. In
both groups, cardiometabolic risk factors were the most
prevalent health conditions, followed by osteoarthritis
and chronic back pain.
Adjusting for age and sex, diabetes was significantly
associated with all chronic conditions except for osteo-
porosis, severe visual and hearing impairment (Table 2).
Further adjustment for educational attainment, region of
residence, BMI, smoking status, and sports activity
generally reduced the strength of the associations. Sig-
nificant associations persisted except for associations
of diabetes with lower respiratory disease, chronic
back pain, and depression (Table 2). Associations withdiabetes were strongest for cardiometabolic and car-
diovascular conditions, chronic renal and chronic liver
disease. An interaction with sex was observed for the
association between diabetes and depression (p = .022). In
sex-specific analyses, women, but not men with diabetes
were significantly more likely to also have depression
(1.57; 95% CI: 1.08-2.30 vs. 0.83; 95% CI: 0.48-1.46).
On average, persons with diabetes had signifi-
cantly more comorbidities than persons without diabetes
(mean ±SD: 3.7±2.4 vs. 2.2±2.0; median: 3 vs. 2, p < .001).
Differences in number of comorbidities between the two
groups were independent of differences in age, sex, BMI,
region of residence, smoking status, sports activities,
and education (data not shown). Significant differences
between persons with and without diabetes were observed
for diabetes-concordant (mean±SD: 2.0±1.3 vs. 1.0±1.1;
median: 2 vs. 1, p < .001) as well as diabetes-discordant
comorbidities (mean±SD: 1.7±1.7 vs. 1.2±1.4; median:
1 vs. 1, p < .001).
Among persons with diabetes, 94.6% (92.3% of men;
96.7% of women) suffered from at least one comorbid
condition and 80.2% (74.0% of men; 85.5% of women)
had two or more comorbidities. By comparison, among
non-diabetics, 78.5% (74.6% of men; 81.8% of women)
had at least one and 56.1% (51.1% of men; 61.4% in
women) had at least two additional chronic conditions
(data not shown).
Patterns of diabetes-concordant comorbidity and severity
of diabetes among diabetics
Table 3 depicts patterns of diabetes-concordant com-
orbidities among diabetics. Total as well as mutually ex-
clusive prevalence estimates are shown for each of the
possible combinations. For example, a total of 872
diabetics or 86.3% had at least one cardiometabolic con-
dition. Among these, more than half (n = 497, 46.8%)
had none of any other concordant comorbidities. Over-
all, 352 diabetics or 37.2% had CVD. Among these,
only a small proportion (n = 25; 2.2%) had CVD alone,
while the vast majority also had at least one
cardiometabolic condition (n = 265; 27.5%) without any
other concordant comorbidities. Smaller proportions of
diabetics with CVD showed other comorbidity patterns,
e. g. n = 27 (3.4%) had any cardiometabolic condition
plus chronic renal disease without severe visual impair-
ment, n = 22 (1.8%) had any cardiometabolic condition
plus severe visual impairment without chronic renal dis-
ease, and n = 7 (0.5%) had any cardiometabolic condi-
tion plus chronic renal disease as well as severe visual
impairment. In sex-specific analyses, similar patterns
were found for men as for women women (data not
shown).
Table 3 further summarizes patterns of diabetes-
concordant comorbidities with respect to diabetes
Table 1 12-month prevalence of known diabetes mellitus among German adults aged 50 years and older (N = 9133) by
socio-demographic and behavioral characteristics
Characteristics Prevalence % (95% CI) Unadjusted OR (95% CI) Adjusted OR (95% CI)
Overall 13.6 (12.7-14.7)
Sex
Men 13.9 (12.5-15.5) 1.04 (0.88-1.24) 1.02 (0.83-1.25)
Women 13.4 (12.1-14.9) 1.00
Age groups ***(yrs)
50-54 6.5 (5.1-8.2) 1.00 1.00
55-59 9.5 (7.9-11.5) 1.51 (1.09-2.09) 1.48 (1.05-2.07)
60-64 11.8 (9.6-14.5) 1.93 (1.37-2.71) 1.96 (1.38-2.78)
65-69 14.2 (11.9-16.8) 2.37 (1.72-3.26) 2.20 (1.56-3.11)
70-74 20.1 (17.1-23.4) 3.60 (2.62-4.96) 3.59 (2.54-5.06)
75+ 19.4 (16.5-22.6) 3.46 (2.52-4.75) 3.55 (2.49-5.05)
Region**
East 17.1 (15.0-19.6) 1.00 1.00
North 13.3 (10.9-16.1) 0.74 (0.56-0.98) 0.73 (0.54-0.98)
Central 13.0 (11.4-14.9) 0.72 (0.58-0.90) 0.71 (0.56-0.91)
South 11.9 (10.1-13.9) 0.65 (0.51-0.83) 0.60 (0.46-0.78)
BMI*** (kg/m2)
< 25 (Normal)# 5.9 (4.9-7.2) 1.00 1.00
≥ 25 (Overweight) 12.5 (11.1-14.2) 2.22 (1.73-2.85) 2.10 (1.63-2.71)
≥ 30 (Obese) 28.7 (25.9-31.8) 6.65 (5.17-8.55) 5.74 (4.42-7.46)
Smoking status***
Current smoker 9.5 (7.9-11.6) 1.00 1.00
Ex smoker 14.9 (13.2-16.7) 1.66 (1.28-2.14) 1.15 (0.87-1.52)
Non-smoker 14.5 (13.0-16.2) 1.61 (1.25-2.07) 1.01 (0.76-1.35)
Sports activity in the past 3 months***
No sports 18.4 (16.7-20.3) 2.44 (1.89-3.15) 1.70 (1.30-2.23)
<4 hours/week 10.6 (9.2-12.1) 1.28 (0.97-1.68) 1.14 (0.86-1.53)
over 4 hours/week 8.4 (6.9-10.4) 1.00 1.00
Educational attainment***
Primary 16.6 (15.0-18.4) 1.99 (1.63-2.43) 1.28 (1.02-1.60)
Middle 11.2 (9.9-12.8) 1.26 (1.02-1.57) 1.04 (0.82-1.32)
High 9.1 (7.9-10.5) 1.00 1.00
National Health Telephone Interview Survey “German Health Update (GEDA)” 2009).
Estimates of 12-month prevalence (%) and their 95% confidence intervals (95% CI) were weighted according to German population statistics (December 31, 2007).
# including 101 (1%) under-weighted subjects whose body mass index (BMI) is less than 18.5 kg/m2.
* p < .05, ** p < .01, *** p < .001, derived from Rao-Scott chi-square tests for the difference of prevalence estimates within specific group.
Adjusted and unadjusted odds ratio (OR) and 95% confidence intervals (95% CI) were derived from logistic regression models. Variables in the adjusted logistic
regression model include all variables listed in Table 1.
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of persons with diabetes had no diabetes-concordant
comorbidities corresponding to severity grade 1; 46.8%
reported hypertension/hyperlipidemia only (grade 2), and
43% had at least one comorbidity likely to represent
major macro- or microvascular end-organ complications
(grade 3). The proportion of persons with diabetes who
had at least one diabetes-discordant condition continuouslyand significantly increased with increasing diabetes severity
grade, ranging from 47.7% (men: 38.2%; women: 60.2%)
among persons with diabetes severity grade 1, to 64.3%
(men: 53.7%; women: 72.2%) among those with severity
grade 2, to 74.9% (men: 67.3%; women: 83.0%) among
those with severity grade 3 and to 93.7% (men: 92.4%;
women: 94.2%) among those with severity grade 4 (data
not shown in Table 3).
Table 2 Prevalence of chronic health conditions and association with known diabetes mellitus among German adults
aged 50 years and older (N = 9133)
Health conditions Diabetics (N = 1035) Non-Diabetics (N = 8098) Model 1 Model 2
Prevalence (%) Prevalence (% ) OR1 95% CI OR2 95% CI
Diabetes-concordant conditions (No. 1–8) 89.8*** 60.4 4.99*** 3.76-6.62 3.71*** 2.76-4.99
1 Hypertension 73.5*** 40.8 3.60*** 2.95-4.40 2.57*** 2.08-3.18
2 Hyperlipidemia 52.8*** 32.4 2.21*** 1.84-2.64 2.00*** 1.65-2.43
Cardiometabolic risk factors (No .1-2) 86.3*** 56.5 4.33*** 3.38-5.55 3.20*** 2.47-4.15
3 Angina pectoris 28.5*** 11.6 2.54*** 2.03-3.18 2.28*** 1.79-2.90
4 Myocardial infarction 14.0*** 5.3 2.50*** 1.86-3.37 2.30*** 1.66-3.19
Coronary Heart Disease (CHD) (No. 3–4) 31.0*** 13.0 2.52*** 2.03-3.13 2.24*** 1.77-2.84
5 Congestive heart failure 10.9*** 4.9 1.97*** 1.43-2.71 1.81*** 1.28-2.57
Diseases of the heart (No.3-5) 34.0*** 15.2 2.38*** 1.93-2.94 2.11*** 1.68-2.65
6 Stroke 7.9*** 3.8 1.80** 1.25-2.59 1.69* 1.13-2.54
Cardiovascular Disease (CVD) (No. 3–6) 37.2*** 17.3 2.35*** 1.91-2.87 2.10*** 1.69-2.62
7 Chronic renal disease 8.3*** 1.8 4.33*** 2.79-6.72 3.72*** 2.30-6.03
8 Severe visual impairment 6.0* 4.1 1.23 0.85-1.78 1.16 0.79-1.71
- -
Diabetes-discordant conditions (No. 9–20) 68.5*** 58.3 1.40*** 1.16-1.69 1.23* 1.00-1.50
9 Asthma 8.9** 5.9 1.47* 1.07-2.02 1.28 0.90-1.80
10 Chronic bronchitis 10.8** 7.0 1.50** 1.12-2.01 1.30 0.96-1.78
Lower respiratory diseases (No.9-10) 14.4*** 9.6 1.48** 1.15-1.91 1.30 0.99-1.71
11 Gastritis/duodenitis 6.3 4.6 1.52* 1.07-2.17 1.51* 1.05-2.16
12 Gastricduodenal ulcers 1.9* 0.7 2.57* 1.21-5.48 2.26* 1.10-4.63
Digestive disorders (No. 11–12) 7.3* 5.0 1.60** 1.13-2.25 1.58* 1.12-2.24
13 Osteoarthritis 42.3*** 31.4 1.50*** 1.25-1.81 1.27* 1.04-1.54
14 Rheumatoid arthritis 14.1*** 7.4 2.01*** 1.52-2.65 1.65*** 1.22-2.23
15 Osteoporosis 12.6 9.9 1.13 0.85-1.51 1.10 0.81-1.49
16 Chronic back pain 34.5*** 26.0 1.45*** 1.20-1.75 1.20 0.98-1.46
Musculoskeletal diseases (No.13-16) 56.5*** 46.5 1.39*** 1.16-1.67 1.19 0.98-1.44
17 Chronic liver disease 5.7*** 1.8 3.30*** 2.10-5.18 2.72*** 1.76-4.19
18 Cancer (any malignancy) 16.8*** 11.4 1.37* 1.07-1.77 1.43** 1.10-1.85
19 Depression 8.6 7.0 1.44* 1.06-1.95 1.24 0.90-1.70
20 Severe hearing impairment 5.5 5.2 0.86 0.57-1.29 0.72 0.47-1.11
National Telephone Health Interview Survey ‘German Health Update (GEDA)’ 2009.
* p < .05, ** p < .01, *** p < .001, Rao-Scott chi-square test for independence of the associations between diabetes and other chronic conditions.
OR1: adjusted for age (continuous variable) and sex.
OR2: adjusted for age (continuous variable), sex, region of residence, body mass index, smoking status, sports activities and educational attainment. * p < .05;
** p < .01, *** p < .001.
CHD: coronary heart disease; CVD: cardiovascular disease; OR: Odds ratio; 95% CI: 95% confidence intervals.
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persons with diabetes
In ordinal regression analyses, the grade of diabetes
severity among persons with diabetes was significantly
and positively related to the total number of diabetes-
discordant comorbidities (Table 4, model 1). Except
for age [cumulative odds ratio (COR) = 1.05, 95% CI:
1.03-1.07 per year] none of the covariables were inde-
pendently related to the grade of diabetes severity(data not shown in Table 4). Current smoking (reference
category: never smoking) was the only independent
variable showing a significant interaction with sex
(p = .014). In sex-specific analyses, current smoking was
significantly associated with the grade of diabetes sever-
ity among women (3.03, 1.37-6.72) but not among men
(0.62, 0.25-1.49).
With respect to specific types of diabetes-discordant
comorbidities, depression, any lower respiratory disease,
Table 3 Prevalence and patterns of diabetes-concordant comorbidity among German adults aged 50 years and older with known diabetes mellitus (N = 1035)









N Prevalence of subjects having the indicated
comorbidities % (95% CI)
N Prevalence of subjects having the indicated
comorbidities only % (95% CI)
120 10.2 (8.0-13.0) Grade 1
(n = 120)
X 872 86.3 (83.2-88.8) 497 46.8 (42.7-50.9) Grade 2
(n = 497)
X 352 37.2 (33.2-41.3) 25 2.2 (1.3-3.7)
X 72 8.3 (6.1-11.2) 4 0.2 (0.1-0.4) Grade 3
X 70 6.0 (4.4-8.0) 8 0.8 (0.3-2.0) (n = 350)
X X 321 33.4 (29.6-37.5) 265 27.5 (24.0-31.4) 35.6%
X X 64 7.4 (5.4-10.2) 24 3.2 (1.8-5.4) (31.7-
39.7%)
X X 59 4.9 (3.5-6.7) 24 2.2 (1.3-3.7)
X X 38 4.7 (3.1-7.1) 3 0.6 (0.2-2.4)
X X 32 2.8 (1.8-4.3) 2 0.3 (0.1-1.1)
X X 14 0.9 (0.5-1.7) 0 0 Grade 4
X X X 8 0.6 (0.3-1.4) 1 0.1 (0.0-0.6) (n = 68)
X X X 29 2.4 (1.5-3.8) 22 1.8 (1.0-3.2) 7.4%
X X X 13 0.8 (0.5-1.6) 6 0.3 (0.1-0.7) (5.4-
10.0%)
X X X 34 3.9 (2.5-6.1) 27 3.4 (2.0-5.5)
X X X X 7 0.5 (0.2-1.2) 7 0.5 (0.2-1.2)
National Telephone Health Interview Survey ‘German Health Update (GEDA)’ 2009.
Cardiometabolic risk factors: hypertension, hyperlipidemia.
CVD: angina pectoris, myocardial infarction, chronic heart failure and stroke.
* Severity of diabetes was defined as: grade 1 = no diabetes-concordant comorbidity; grade 2 = any cardiometabolic condition without further diabetes-concordant comorbidity; grade 3 = any one diabetes-
concordant end-organ complications (CVD or chronic renal disease or several visual impairment) irrespective of cardiometalic conditions; grade 4 =two or more diabetes-specific end-organ diseases irrespective of




















Table 4 Association between diabetes-discordant comorbidities and diabetes severity among German adults aged
50 years and older with known diabetes mellitus (N = 1035)
COR1 95% CI COR2 95% CI
Model 1
No. of diabetes-discordant comorbidities 1.38 1.24-1.53 1.40 1.25-1.55
Model 2
Type of diabetes-discordant comorbidities
Lower respiratory disease 2.59 1.66-4.05 2.75 1.72-4.40
Digestive disease 1.34 0.76-2.39 1.42 0.79-2.57
Musculoskeletal diseases 1.54 1.07-2.21 1.53 1.06-2.21
Chronic liver disease 1.79 0.87-3.67 1.86 0.84-4.16
Any cancers 0.67 0.41-1.11 0.63 0.38-1.07
Depression 2.07 1.23-3.48 2.21 1.33-3.67
Severe hearing impairment 2.93 1.16-7.37 2.90 1.17-7.15
National Health Telephone Interview Survey ‘German Health Update (GEDA)’ 2009.
COR = Cumulative odds ratios (COR) as obtained from multivariable ordinal regression analysis with grade of diabetes severity (grade 1–4) as the
dependent variable.
COR1: adjusted for age (continuous variable) and sex.
COR2: adjusted for age (continuous variable), sex, region of residence, body mass index, smoking status, sports activities and educational attainment.
Model 1: with no. of diabetes-discordant comorbidities as explanatory variable.
Model 2: with types of diabetes-discordant comorbidities as explanatory variables.
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ment were significantly and positively associated with
severity of diabetes (Table 4, model 2). No significant
interactions with sex were observed (data not shown in
Table 4). Considering the different pathophysiological
mechanisms underlying the four conditions grouped as
musculoskeletal diseases, we also investigated the ef-
fect of each condition separately. All four conditions
except for osteoporosis were significantly and posi-
tively associated with the grade of diabetes severity
(data not shown).
Discussion
The present study provides nationally representative
data on the prevalence and comorbidity of known
diabetes among older non-institutionalized adults in
Germany. The overall 12 month-prevalence of known
diabetes was high at 13.6% with no difference between
men and women. Although we did not collect information
about the type of diabetes, it can be generally assumed
that the vast majority of diabetes identified from older
adults aged over 50 years were type-2 diabetes. Persons
with known diabetes were significantly more likely to
suffer from additional chronic health conditions than
persons without diabetes, irrespective of potential
confounders. As expected, these associations were most
pronounced for diabetes-concordant comorbidities,
i. e. conditions in the pathophysiological pathway of
diabetes. Severity of diabetes classified as grade 1–4
according to the type and number of concordantcomorbidities positively and independently correlated with
age and the number of diabetes-discordant comorbidities
as well as with specific diabetes-discordant conditions
including depression, chronic lower respiratory disease,
musculoskeletal disease, and severe hearing impairment.
Prevalence of known diabetes
The prevalence of diabetes varies considerably between
countries [29] and even between regions within a
given country [30]. This may be partly explained by
differences in ethnic or socioeconomic background as
well as differences in health care systems [31]. How-
ever, comparisons between studies are often compromised
by methodological differences regarding data collection
mode, the age range of the study population, and the
diagnostic criteria used to define diabetes. In the present
study, we used 12-month-prevalence estimates. Previous
sex and age stratified analysis of GEDA 2009 data in-
cluding study participants of all age groups showed that
lifetime prevalence estimates were consistently higher
than 12-month-prevalence estimates with absolute over-
all differences of 1.8% among women and 1.0% among
men [22]. The largest differences were found among
women in the age group 30–44 (2.5%) and 65+ years
(2.7%) [22], probably reflecting gestational diabetes.
In Germany, several nationwide health surveys have
been conducted since the reunification using standard-
ized computer-assisted interview technique, either via
telephone or face-to-face interview [11,32, Heidemann
C, Du Y, Schubert I, Rathmann W, Scheidt-Nave C:
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Results of the German Health Interview and Examination
Survey for Adults (DEGS1). Bundesgesundheitsblatt
Gesundheitsforschung Gesundheitsschutz 2013. Forth-
coming]. In these previous surveys, age-specific prevalence
estimates in older age groups are similar to those observed
in the present study [11]. In contrast, prevalence estimates
obtained from health insurance claim data [14,15] have
been consistently higher than results of national health
surveys. This has partly been explained by selection bias,
as most analyses are derived from AOK (Allgemeine
Ortskrankenkasse) data. The AOK is a large German
sickness fund insuring a particularly high proportion
of older persons, persons with multiple concurrent
health problems and persons on social welfare. Infor-
mation on health insurance provider was obtained in
GEDA, which permitted the calculation of diabetes
prevalence estimates stratified by insurance company.
Persons insured by the AOK were significantly more
likely to have known diabetes compared to those insured by
other providers (data not shown). This was also demon-
strated in previous national health interview surveys
conducted by telephone or postal questionnaires as well as
in recent national health examination surveys based on two-
stage stratified random sampling from local population
registries [16,32, Heidemann C, Du Y, Schubert I, Rathmann
W, Scheidt-Nave C: Prevalence and temporal trend
of known diabetes mellitus. Results of the German
Health Interview and Examination Survey for Adults
(DEGS1). Bundesgesundheitsblatt Gesundheitsforschung
Gesundheitsschutz 2013. Forthcoming]. The prevalence
estimates of known diabetes among persons with AOK
insurance observed in our study were similar to published
prevalence estimates based on data from the AOK Hesse
[15]. A recent pooled analysis of several regional
population-based studies demonstrated considerable
regional differences in the prevalence of known type-2
diabetes; in agreement with our results, prevalence
estimates were highest in the eastern parts of Germany
[12]. The underlying reasons are subject to ongoing investi-
gation (http://www.kompetenznetz-diabetes-mellitus.net).
Extending comparisons to results of national health surveys
in other western countries, our recalculated age and sex-
specific prevalence estimates were comparable to those
reported in the US National Health and Nutrition Examin-
ation Survey 2003–2006 [33] and in the French Nutrition
and Health Survey 2006–2007 [34] among persons 50–74
years of age. Among persons 75 years of age and above, our
prevalence estimates exceed those obtained in the US study
[33] and in the annual Health Survey for England
1994–2006 [35]. However, differences in the definition of
known diabetes need to be considered, e. g. lifetime vs.
12-month prevalence estimates and exclusions of women
with gestational diabetes.Associations between diabetes and other chronic
conditions
In the present study, diabetes was significantly associated
with a wide range of chronic conditions. The strength of
these associations was most pronounced for diabetes-
concordant comorbidities, including cardiometabolic risk
factors, cardiovascular disease and chronic renal disease.
These conditions are well known to be in the pathophysio-
logical pathway of diabetes [36]. Self-reported severe visual
impairment was not significantly related to diabetes in
our study after adjusting for age and other covariables.
There are several possible explanations for this. First,
visual impairment is strongly related to older age, causes
other than diabetic retinopathy prevail in older compared
to younger persons with diabetes [37-40]. Thus, the differ-
ence between persons with and without diabetes may be
less pronounced in older age. Secondly, self-reported
visual impairment does not permit to differentiate be-
tween uncorrectable and correctable visual impairment.
Uncorrectable but not correctable visual impairment
as assessed by measurements of visual acuity and
automated refraction was significantly more prevalent
among adults with than without diabetes in the National
Health Interview and Examination Survey (NHANES)
1999–2004 after adjustment for confounders [37]. Fi-
nally, the risk of severe visual impairment due to micro-
vascular complications increases with the duration of
diabetes [40] and long-standing diabetes may be
underrepresented in our survey.
We also observed significant associations between
diabetes and diabetes-discordant comorbidities, i. e.
comorbidities less evidently related to diabetes. Previous
studies reported associations of diabetes with chronic
liver disease [41] and various types of cancer [42]. Study
results regarding the relation between diabetes and
musculoskeletal conditions are less consistent [43,44].
A relation between diabetes and certain site-specific
cancers has been attributed to hyperinsulinemia, but
the causal link is still subject to debate [45]. We
observed no independent association between diabetes
and asthma or chronic bronchitis. Results of previous
investigations of these associations are conflicting
[46,47]. The association of diabetes with upper gastro-
intestinal tract disease may imply helicobacter pylori
infection as a possible common pathway of the two
diseases [48]. Unlike previous studies, we did not ob-
serve a significant association between a history of dia-
betes and self-reported severe hearing impairment [49].
Also in contrast with earlier reports [50], an associ-
ation between diabetes and depression was restricted
to women in the present study. We cannot exclude
that associations of diabetes with both conditions were
biased towards the null in the present study due to
non-participation.
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diabetics
One of the key goals of diabetes management programs
is to prevent diabetes-concordant complications involv-
ing target organ damage. In our study, 43% of persons
with known diabetes reported at least one such
comorbidity. Few previous studies have systematically
analyzed comorbidity patterns in population-based samples
of persons with diabetes. In the German DETECT study
of diabetic patients recruited from a nationwide sample
of general practices, half of patients with type-2 diabetes
(50.2%) had at least one diabetes-related micro- or
macrovascular complication [17]. Similar results were
also found in other studies conducted in Germany
[18,51]. In a population of patients with diabetes identi-
fied from South Glamorgan in the UK, Morgan et al.
found that 25.2%, 9.6%, 18.1%, 16.5% and 2.0% of dia-
betic patients had CHD, cerebrovascular disease, dia-
betic foot, retinopathy and nephropathy, respectively,
while 52% of diabetic patients had none of these studied
micro- and macro-vascular complications [52]. These
results have been confirmed by additional regional
investigations in the UK [53]. In summary, results from
previous studies regarding the proportion of persons
with diabetes who also have severe diabetes-related end-
organ disease are roughly in line with our observations.
Direct comparisons between studies are precluded by
differences in study design, setting, mode of data collec-
tion as well as the type of diabetes-related comorbidities
considered.
Within the given limits of the available database, we
classified diabetes severity based on the type and num-
ber of diabetes-concordant comorbidities. The grading
system presented here is self-developed based on evi-
dence derived from published studies of comorbidity. It
is well known that treatment and prognosis of persons
with diabetes mellitus or any other index disease is
likely to be influenced by co-existing health conditions,
whether they are in the pathophysiologic pathway of the
index disease or not [26]. This is particularly true
among older persons with diabetes who tend to have
multiple health conditions. In order to describe diabetes
comorbidity in a comprehensive and systematic way, we
applied the idea of the Cumulative Illness Rating Scale
(CIRS), aggregating individual health problems according
to organ systems [54,55]. From a public health perspective,
it seemed crucial to develop a grading system of diabetes
comorbidity that would not only permit to differentiate
between diabetes-concordant and diabetes-discordant
comorbidities, but also between target organ complications
of diabetes and systemic cardiometabolic conditions likely
to coexist or even to precede the onset of diabetes, such as
hyperlipidemia. The proportion of persons with diabetes
mellitus who already have macro- or microvascularcomplications may serve as an indicator to monitor time
trends and spatial distributions of diabetes management
and quality of care.
While we think this is a step in the right direction,
criteria of diabetes severity in population-based epi-
demiological studies need to be refined and consented
to be clinically relevant and to permit comparisons
between studies. In particular, there is need for studies
including objective measures of concomitant cardio-
metabolic risk factors (e. g. blood pressure, serum
lipids), glucose control (glycosylated hemoglobin), in-
flammation (high sensitivity C-reactive protein) and
diabetes-related complications (neuropathy, diabetic foot,
diabetic retinopathy, diabetic nephropathy). In addition,
characteristics of patient complexity (living alone, de-
pressive symptoms, cognitive impairment) need to be
considered. In the present study, we observed a signifi-
cant and independent association between diabetes se-
verity and depression, chronic lower respiratory disease,
musculoskeletal disease, and severe hearing impairment.
These results may indicate an interactive effect of dia-
betes and other chronic conditions on cardiovascular
target organ damage. In fact, results from epidemio-
logical studies have suggested that CVD may be related
to depression [56], chronic obstructive pulmonary dis-
ease [57], osteoarthritis [58], and rheumatoid arthritis
[59]. Further, all these conditions tend to co-exist with
CVD in older individuals and may hence interfere
with effective patient counseling and treatment [60].
Hearing impairment may interfere with the severity of
diabetes. In a retrospective analysis of laboratory and
audiometric data of diabetic patients, progression of
diabetes correlated with worsening of hearing ability [61].
Strengths and limitations
GEDA 2009 is a nationally representative recent health
telephone survey with a large sample size and comprehen-
sive information on self-reported physician-diagnosed
chronic conditions. We assessed systematically concordant
and discordant comorbidities of diabetes. However, there
are several limitations.
First and most importantly, we have to consider selec-
tion bias. This national health survey is confined to the
non-institutionalized population. Regarding the popula-
tion in private households, selection bias due to the
exclusion of persons residing in households without
landline telephones is possible. There is evidence that
the proportion of persons exclusively using a mobile
phone is increasing, particularly among younger adults
living on their own [62]. As the present analysis was
confined to persons aged 50 years and older, selective
underrepresentation of this particular subgroup can be
expected to be small. However, given a cooperation
rate of 51.2% at the respondent level, we cannot
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ment weights were applied as computed from deviations
between study participants and census data for the non-
institutionalized German population within strata of age,
sex, educational attainment, and region (see Additional file
1 and Additional file 2). Nevertheless, non-responders
may well differ from study participants with respect to
other characteristics relevant to the study variables of
major interest and these differences may have biased our
results. Data regarding diabetes-related risk factors based
on census data are scarce and limited to smoking and
BMI computed from self-reported body weight and height.
Comparing age specific prevalence estimates of smoking
and BMI status obtained in the present study to estimates
derived from the Microcensus 2009 did not demonstrate
significant underestimation of these risk factors (see
Additional file 3).
Secondly, GEDA 2009 was not specifically designed
for the investigation of diabetes and its complications,
hence information on treatment, type or duration of dia-
betes was not collected. Type 2 diabetes can be assumed
to predominate in the adult population. However, infor-
mation on duration of diabetes and metabolic control
would have been useful to test the hypothesis that these
factors are related to higher comorbidity. This should be
addressed in future studies of diabetes comorbidity.
Third, the definition of some chronic conditions was ra-
ther crude. For example, we asked survey participants
about any cancer without differentiation between spe-
cific types of cancer. However, some cancers are more
common in patients with diabetes, while prostate cancer
occurs less often in men with diabetes compared to
those without diabetes [45,63]. Furthermore, some of the
disease categories such as ‘musculoskeletal disease’ prob-
ably included pathogenetically heterogeneous conditions.
Finally, information on diabetes and all other 20
chronic health conditions was self-reported and verifica-
tion by medical records and/or laboratory tests was not
possible. Assessment of health conditions by self-report
bears the risk of misclassification due to over- or
underreporting. Persons with diabetes may be more
likely to report asymptomatic diabetes-related health
conditions such as hypertension and hyperlipidemia than
persons without a diagnosis of diabetes, due to higher
health care services utilization [64]. On the other hand,
survey participants, in particular older persons may be
unable to name or to memorize medical diagnoses cor-
rectly. A validation of self-reported diagnoses against ob-
jective health data (e. g. biochemical measurements and
current medication use) in the Utrecht Health Project
demonstrated that assessment by self-report is likely to
lead to underestimation of disease prevalence estimates.
The magnitude of bias varies according to the type of dis-
ease as well as the population studied [65]. Nevertheless,our prevalence estimates for diabetes and other highly
prevalent health conditions are well in line with
estimates from other populations-based studies [33,34]
as well as one recent German study conducted in the
primary care setting [21]. The validity of our indicator
for diabetes is further supported by the fact that
associations of known diabetes to sociodemographic
variables and major established risk factors of diabetes
were all highly significant and in the expected directions
(Table 1).
Conclusions
Among non-institutionalized German adults 50 years
of age and older, the 12-month prevalence of persons
with known diabetes is high and does not significantly
differ between men and women. Diabetes is signifi-
cantly associated with a wide spectrum of chronic
comorbidities, including conditions that are directly in
the pathway of diabetes as well as others that may indir-
ectly contribute to adverse diabetes outcomes. Among
persons with known diabetes, 43.0% had at least one
condition likely to represent micro- or macrovascular
complications of diabetes; another 46.8% had at least
one out of two major cardiometabolic risk factors
known to be pathophysiologically related to diabetes
(hypertension, hyperlipidemia). Although these diabetes-
concordant comorbidities may largely contribute to the
disease burden among diabetics, the number and the type
of diabetes-discordant comorbidities seem to matter as
well. In particular, depression, lower respiratory disease
and severe hearing impairment were closely associated
with severity of diabetes defined by the pattern of
diabetes-concordant comorbidities. In conclusion, diabetes-
concordant as well as diabetes-discordant comorbidities
need to be considered for monitoring of disease burden
and quality of diabetes care in population-based epidemio-
logical studies. Definitional standards need to be refined
and consented to permit comparisons between studies and
analyses of time trends and spatial distributions.Additional files
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